Thursday, September 17, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Compoundingquvacaps503bsterile compounding

Quva acquires CAPS 503B sterile compounding product portfolio

The deal expands Quva's outsourcing-facility footprint in sterile compounded medications for hospitals.

MH
By Maren Holt · Senior Reporter, GLP-1
Sep 12 10:20 ETSource: Pulse 2.0

The wire

  1. 01Quva agreed to acquire the 503B sterile compounding product portfolio of CAPS.
  2. 02Consolidation among 503B outsourcing facilities concentrates hospital sterile drug supply.
  3. 03Deal terms and closing timeline were not detailed in the excerpt.

From the source

Quva Acquires CAPS 503B Sterile Compounding Product Portfolio

Read at news.google.com
Source URL https://news.google.com/rss/articles/CBMiiAFBVV95cUxPT1ZXVkVtUkZxUGw0ZEZLR3FSY2hOUGg5b3FhWEx4N2hJRWNobmo1Mm8wZVRkaEFUR1IzYWUtcGdvTEJ1Q3ZCTmRBamZ0NDdZU1QyczJZZ0wwZEhZRlZNUTE4QXI3ZnZGVFlFOFRFRnZ4ejlWZ0UzYjIxTGVFd2s0cXI2ME15Mlot0gGOAUFVX3lxTFA1TkJqc2w3anFhWWNESl9GdHhDRFotY2hkZ3AwQVdndUFZaW1CY0U1Rmc2NlMzYjdqcU1zYXJFTUs3Z2F1Tlp2V2M1M3RJTU5VRTdPdnJneTlXS0REOGpHN3E3ak51eThURU5HUHNEOENvVzkwbGlDRVZnQ0RRb3hQbEgxdmZjQ044TjNLRmc?oc=5